Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
We have previously reported that despite neonatal screening, children with severe congenital hypothyroidism treated at 5 weeks of age with 6 micrograms/kg.day levothyroxine have clinically significant intellectual impairment, whereas those with the moderate form of the disease are indistinguishable from controls. The developmental outcome of children with severe congenital hypothyroidism treated earlier with higher initial doses of levothyroxine remained to be determined. In the present study, 45 infants with permanent congenital hypothyroidism detected by neonatal screening are described. For the group, the median age at starting treatment was 14 days, and the median initial dose of levothyroxine was 11.6 micrograms/kg.day. Based on the area of their knee epiphyses at diagnosis, the patients were divided into 2 subgroups: severe (< 0.05 cm2; n = 10) and moderate (> or = 0.05 cm2; n = 35). The psychomotor development of 8 patients in each subgroup, matched for the socioeducational level of their families, was assessed at 18 months. Mean plasma free T4 levels were supraphysiological during the first few months of life, but mean plasma T3 levels remained within the normal range, and there were no signs or symptoms of hyperthyroidism. The mean plasma TSH concentration was less than 4.5 mIU/L 4 weeks after starting treatment. Bone maturation remained delayed at 12 months in the severe cases and was not unduly advanced in the moderate cases. The mean (+/- SD) developmental quotients at 18 months were similar in severe and moderate cases (107 +/- 10 and 110 +/- 5, respectively). We conclude that with earlier treatment and a higher initial dose of levothyroxine, the early developmental outcome of infants with severe congenital hypothyroidism is now indistinguishable from that of infants with the moderate form of the disease who were used as controls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vulsma, T., Gons, M. H., & de Vijlder, J. J. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210103 · Cited by 795
Improved prognosis in congenital bypothyroidism treated before age three months
Klein, A. H., Meltzer, S., & Kenny, F. M. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80542-0 · Cited by 323
Kooistra, L., Laane, C., Vulsma, T., Schellekens, J. M. H., van der Meere, J. J., & Kalverboer, A. F. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83178-6 · Cited by 185
Tillotson, S. L., Fuggle, P. W., Smith, I., Ades, A. E., & Grant, D. B. (1994) · BMJ · doi:10.1136/bmj.309.6952.440 · Cited by 177 · cited 3×
“(12) confirms that there is a threshold effect of congenital hypothyroidism on intelligence.”
BackgroundPremature craniosynostosis—a complication of thyroid replacement therapy
Penfold, J. L., & Simpson, D. A. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80963-2 · Cited by 75 · cited 2×
“Craniosynostosis and psychomotor retardation have been described as a result of overtreatment of congenital hypothyroidism (39); however, these complications resulted from levothyroxine doses that were many orders of magnitude (up to 500 PLg daily) higher than the dose currently recommended.”
Background
Cited by
Thyroid Hormones and Brain Development
Bernal, J. (2005) · Vitamins & Hormones · doi:10.1016/s0083-6729(05)71004-9 · Cited by 471
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“However, relative macrocrania at the age of 18 months, but without any case of craniosynostosis, was reported in a cohort of 45 CH patients with documented fT4 concentrations above the reference interval during their first 6 to 9 months of life (117).”
BackgroundGenetics of congenital hypothyroidism
Park, S. M., & Chatterjee, V. K. K. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024158 · Cited by 403
Action of thyroid hormone in brain
Bernal, J. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344003 · Cited by 358
The Potential Repercussions of Maternal, Fetal, and Neonatal Hypothyroxinemia on the Progeny
Glinoer, D., & Delange, F. (2000) · Thyroid · doi:10.1089/thy.2000.10.871 · Cited by 262
Devos, H., Rodd, C., Gagné, N., Laframboise, R., & Van Vliet, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5831 · Cited by 204
“The screening and evaluation procedure has been previously described (17); if the TSH level, measured on dried blood spots collected on filter paper after 24 h of life, is more than 30 mIU/L, the neonate is immediately referred for evaluation and treatment; if the TSH concentration is 15–30 mIU/L, another sample is re…”
MethodOerbeck, B., Sundet, K., Kase, B. F., & Heyerdahl, S. (2003) · Pediatrics · doi:10.1542/peds.112.4.923 · Cited by 176
Momotani, N., Yoshimura Noh, J., Ishikawa, N., & Ito, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4347 · Cited by 171
Perry, R., Heinrichs, C., Bourdoux, P., Khoury, K., Szöts, F., Dussault, J. H., Vassart, G., & Van Vliet, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011995 · Cited by 167
Self-citationSalerno, M., Militerni, R., Bravaccio, C., Micillo, M., Capalbo, D., Di Maio, S., & Tenore, A. (2002) · Thyroid · doi:10.1089/105072502753451968 · Cited by 165
“Several investigators (9,11,12) have suggested that patients with CH have probably been undertreated using the previously recommended dose of 6–8 m g/kg per day.”
InfluentialPsychoeducational Outcome in Children With Early-Treated Congenital Hypothyroidism
Rovet, J. F., & Ehrlich, R. (2000) · Pediatrics · doi:10.1542/peds.105.3.515 · Cited by 129
Kempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, M. W. G., Kooistra, L., Wiedijk, B. M., Faber, I., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1209 · Cited by 122
“Indeed, some studies indicate that even patients with severe CH, assessed in the first 3 yr of life, had normal cognitive and motor outcomes if treatment started early and with high initial T4 doses (25, 26).”
BackgroundSimoneau-Roy, J., Marti, S., Deal, C., Huot, C., Robaey, P., & Van Vliet, G. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.021 · Cited by 123
Self-citationDimitropoulos, A., Molinari, L., Etter, K., Torresani, T., Lang-Muritano, M., Jenni, O. G., Largo, R. H., & Latal, B. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31818d2030 · Cited by 114
“Some studies have used bone age to classify disease severity (10,24).”
BackgroundResultInitial treatment dose of L-thyroxine in congenital hypothyroidism
Selva, K. A., Mandel, S. H., Rien, L., Sesser, D., Miyahira, R., Skeels, M., Nelson, J. C., & LaFranchi, S. H. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.128887 · Cited by 99
Children With Congenital Hypothyroidism and Their Siblings: Do They Really Differ?
Rovet, J. F. (2005) · Pediatrics · doi:10.1542/peds.2004-1492 · Cited by 98
Relationship of Etiology to Treatment in Congenital Hypothyroidism
Hanukoglu, A., Perlman, K., Shamis, I., Brnjac, L., Rovet, J., & Daneman, D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7124 · Cited by 93
“recent data also support this view (11, 16).”
ResultKempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, R. W. G., Lanting, C. I., Kooistra, L., Wiedijk, B. M., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1538 · Cited by 85
“920 J Clin Endocrinol Metab, March 2007, 92(3):919–924 Kempers et al.”
BackgroundInfluentialCarswell, J. M., Gordon, J. H., Popovsky, E., Hale, A., & Brown, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3125 · Cited by 83
Intellectual outcome at 12 years of age in congenital hypothyroidism
Salerno, M., Militerni, R., Di Maio, S., Bravaccio, C., Gasparini, N., & Tenore, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410105 · Cited by 81
Albert, B. B., Heather, N., Derraik, J. G. B., Cutfield, W. S., Wouldes, T., Tregurtha, S., Mathai, S., Webster, D., Jefferies, C., Gunn, A. J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1903 · Cited by 75
“Nonetheless, high-dose levothyroxine treatment is associated with an increased risk of supraphysiological free T4 (FT4) levels (21), which may lead to difficult temperament in infancy (22) and more frequent attention, behavioral, and psychiatric problems in childhood (17).”
BackgroundCongenital Hypothyroidism: Developmental Outcome in Relation to Levothyroxine Treatment Variables
Heyerdahl, S., & Oerbeck, B. (2003) · Thyroid · doi:10.1089/105072503770867200 · Cited by 73
Cassio, A., Monti, S., Rizzello, A., Bettocchi, I., Baronio, F., D'Addabbo, G., Bal, M. O., & Balsamo, A. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.11.070 · Cited by 68
“Nonetheless, close monitoring and more frequent examinations during the first months of treatment are needed to carefully adjust the dosage at the individual level and to avoid the risk of overtreatment.(20) Regarding cardiac evaluation, pulse rate, recorded at each examination, was found to be in the normal range for…”
BackgroundWasniewska, M., De Luca, F., Cassio, A., Oggiaro, N., Gianino, P., Delvecchio, M., Aiazzi, R., Stoppioni, V, Lombardo, F., Messina, M., et al. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490001 · Cited by 67
Aleksander, P. E., Brückner-Spieler, M., Stoehr, A.-M., Lankes, E., Kühnen, P., Schnabel, D., Ernert, A., Stäblein, W., Craig, M. E., Blankenstein, O., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01937 · Cited by 64
Balhara, B., Misra, M., & Levitsky, L. L. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.10.006 · Cited by 32
Delvecchio, M., Vigone, M. C., Wasniewska, M., Weber, G., Lapolla, R., Popolo, P. P., Tronconi, G. M., Di Mase, R., De Luca, F., Cavallo, L., et al. (2015) · Italian Journal of Pediatrics · doi:10.1186/s13052-015-0190-y · Cited by 22
Tuhan, H., Abaci, A., Cicek, G., Anik, A., Catli, G., Demir, K., & Bober, E. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0047 · Cited by 21
Zdraveska, N., Anastasovska, V., & Kocova, M. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0446 · Cited by 15
Metadata
- Authors
- Dubuis, J. M.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1996-01-01
- Volume
- 81
- Issue
- 1
- Pages
- 222-227
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2065639952
- Cited by
- 194
- References
- 5
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.